AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Piper Jaffray 24th Annual Healthcare Conference at The New York Palace in New York, NY. The presentation is scheduled for Tuesday, November 27, 2012 at 11:00 a.m. ET/8:00 a.m. PT.
SOURCE AcelRx Pharmaceuticals, Inc.
RELATED LINKS
http://www.acelrx.com
More by this Source
AcelRx Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare
May 29, 2013, 07:30 ET
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
May 21, 2013, 07:30 ET
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 16, 2013, 15:20 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen
